Kisselev A F, Akopian T N, Woo K M, Goldberg A L
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Biol Chem. 1999 Feb 5;274(6):3363-71. doi: 10.1074/jbc.274.6.3363.
Knowledge about the sizes of peptides generated by proteasomes during protein degradation is essential to fully understand their degradative mechanisms and the subsequent steps in protein turnover and generation of major histocompatibility complex class I antigenic peptides. We demonstrate here that 26 S and activated 20 S proteasomes from rabbit muscle degrade denatured, nonubiquitinated proteins in a highly processive fashion but generate different patterns of peptides (despite their containing identical proteolytic sites). With both enzymes, products range in length from 3 to 22 residues, and their abundance decreases with increasing length according to a log-normal distribution. Less than 15% of the products are the length of class I presented peptides (8 or 9 residues), and two-thirds are too short to function in antigen presentation. Surprisingly, these mammalian proteasomes, which contain two "chymotryptic," two "tryptic," and two "post-acidic" active sites, generate peptides with a similar size distribution as do archaeal 20 S proteasomes, which have 14 identical sites. Furthermore, inactivation of the "tryptic" sites altered the peptides produced without significantly affecting their size distribution. Therefore, this distribution is not determined by the number, specificity, or arrangement of the active sites (as proposed by the "molecular ruler" model); instead, we propose that proteolysis continues until products are small enough to diffuse out of the proteasomes.
了解蛋白酶体在蛋白质降解过程中产生的肽段大小,对于全面理解其降解机制以及蛋白质周转和主要组织相容性复合体I类抗原肽生成的后续步骤至关重要。我们在此证明,来自兔肌肉的26S和活化的20S蛋白酶体以高度连续的方式降解变性的、未泛素化的蛋白质,但产生不同的肽段模式(尽管它们含有相同的蛋白水解位点)。对于这两种酶,产物长度范围为3至22个残基,并且根据对数正态分布,其丰度随着长度增加而降低。不到15%的产物是I类呈递肽段的长度(8或9个残基),三分之二的产物太短而无法在抗原呈递中发挥作用。令人惊讶的是,这些含有两个“胰凝乳蛋白酶样”、两个“胰蛋白酶样”和两个“酸性后”活性位点的哺乳动物蛋白酶体,产生的肽段大小分布与具有14个相同位点的古细菌20S蛋白酶体相似。此外,“胰蛋白酶样”位点的失活改变了产生的肽段,但没有显著影响其大小分布。因此,这种分布不是由活性位点的数量、特异性或排列决定的(如“分子尺子”模型所提出的);相反,我们提出蛋白水解会持续进行,直到产物小到足以从蛋白酶体中扩散出来。